Threshold Settles Shareholder Action For $10M
Threshold Pharmaceuticals Inc. has agreed to pay $10 million to settle a securities fraud action that alleged the biotechnology company and its top executive misled investors ahead of its initial public...To view the full article, register now.
Already a subscriber? Click here to view full article